Pulmonology Medical News about Adenocarcinoma Adenocarcinoma, Bronchiolo-Alveolar Lung Neoplasms

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. 2008 Exclusive Survey—Earnings: Good news for primary care income

3. Medicare pay-for-reporting effort draws fire from frustrated doctors

4. Debunking Myths in the US Healthcare System

5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lung Adenocarcinoma with EGFR Amplification Has Distinct Clinicopathologic and Molecular Features in Never-Smokers
Cancer Research, 11/02/09

Sholl LM et al. – Lung adenocarcinomas with EGFR amplification have a unique association with exon 19 deletion mutations and show distinct clinicopathologic features associated with a significantly worsened prognosis. In these cases, EGFR amplification is heterogeneously distributed, mostly in areas with a solid histology.

<< Previous
Mechanisms behind Local Immunosuppression Using Inhaled...

Next >>
Assessment of global capacity to conduct tuberculosis drug...

Use of EGFR/KRAS Mutation Testing To Define Clonal Relationships Among Multiple Lung Adenocarcinomas
Chest, 10/08/09 Relevance Score: 93%

Expression of RACK1 is a novel biomarker in pulmonary adenocarcinomas
Lung Cancer, 11/06/09 Relevance Score: 89%

Diagnostic Efficacy of PET/CT Plus Brain MR Imaging for Detection of Extrathoracic Metastases in Patients with Lung Adenocarcinoma
Journal of Korean Medical Science, 11/16/09 Relevance Score: 83%

An Embryonic Stem Cell–Like Signature Identifies Poorly Differentiated Lung Adenocarcinoma but not Squamous Cell Carcinoma
Clinical Cancer Research, 10/12/09 Relevance Score: 82%

Clinicopathological predictors of EGFR/KRAS mutational status in primary lung adenocarcinomas
Modern Pathology, 10/28/09 Relevance Score: 81%